Multiple Sclerosis: all 3,525 studies
Page 19 of 36. Open to participants first (669), then studies with results posted, then the rest; newest registration first within each.
- Investigation of Hand Functions and Related Parameters in People With Multiple SclerosisStatus unknownNCT04933110
- Tele-Assessment and Face-to-Face Evaluation of Functional Gait Assessment in Multiple SclerosisStatus unknownNCT04932616
- Feasibility of Neuromodulation With Connectivity-Guided iTBS for Cognitive Impairment in MSStatus unknownNCT04931953Not applicable
- Description of Adherence to the Main Preventive Health Campaigns of Persons With Multiple SclerosisStatus unknownNCT04930380
- The Gut Microbiome in Adult Multiple SclerosisCompletedNCT04929145
- Multiple Sclerosis and Voiding Symptoms: How to Assess?CompletedNCT04928716
- Safety and Effectiveness of Cinnomer® (Glatiramer Acetate) in Multiple Sclerosis (MS) Treatment in IranCompletedNCT04928313
- Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple SclerosisActive, not recruitingNCT04926818Phase 3
- Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl FumarateWithdrawnNCT04925778
- EEG and TMS-based Biomarkers of ALS, MS and FTDStatus unknownNCT04918251
- Exercise Booster Sessions in People With Multiple SclerosisCompletedNCT04913012Not applicable
- Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Relapsing Forms of Multiple SclerosisSuspendedNCT04909502Phase 2
- A Comprehensive Assessment of Trunk, Scapula and Upper Limb in Neurological Patients. Reliability, Validity and InterrelatednessCompletedNCT04908891Not applicable
- Creating Satisfying Engagement in Daily Life Through Coaching for People With Multiple SclerosisCompletedNCT04908085Not applicable
- Next-Gen MS: Feed-forward PRO Data for MS ResearchTerminatedNCT04907305
- Pilot Investigation to Evaluate FlowOx2.0™ for Experimental Treatment of SpasticityCompletedNCT04904016Not applicable
- The Possible Neuroprotective Effect of Ocrelizumab Via VEGF Protein Expression in Relapsing Multiple Sclerosis PatientsStatus unknownNCT04902690
- Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional StudyTerminatedNCT04895202
- Adapting MHealth Technology to Improve Patient ActivationCompletedNCT04893590Not applicable
- Investigation of the Effects of Technology Supported Different Physiotherapy Approaches on Patients With Multiple SclerosisCompletedNCT04891341Not applicable
- Holter of Movement in Patients with Multiple Sclerosis in Controlled Environment.CompletedNCT04888689Not applicable
- The Effects of Respiratory-based Telerehabilitaion in Patients With MSStatus unknownNCT04887051Not applicable
- Holter of Movement in Patients with Multiple Sclerosis in Uncontrolled Environment.Active, not recruitingNCT04882891Not applicable
- Sport, Rehabilitation and Nutrition in Multiple Sclerosis: The LINUS ProjectStatus unknownNCT04881422Not applicable
- Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple SclerosisWithdrawnNCT04880577Phase 2
- EMDR for Depressed People With Multiple SclerosisStatus unknownNCT04875832Not applicable
- Investigation of the Effect of Ocrelizumab on Peripheral Lymphocyte Immunophenotypes with Suppressive Capacity in MSActive, not recruitingNCT04874597
- Sensor-based Assessment and Rehabilitation of Balance in Neurological DiseasesStatus unknownNCT04874051Not applicable
- Validation of a Novel Instrument Task for Assessing Upper LimbCompletedNCT04868370
- COVID-19 and Multiple Sclerosis Disease Modifying TherapiesStatus unknownNCT04863586
- Assessment of NfL and GFAP Levels, Atrophy of the Macula GCC by OCT and Whole Brain Atrophy by MRI to Predict Evolution of Neurological Disability in MS PatientsActive, not recruitingNCT04860947
- Validation of the French Adaptation of the MSWDQ-23 QuestionnaireCompletedNCT04860791
- MS Relapses During COVID-19 PandemicCompletedNCT04858763
- Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple SclerosisStatus unknownNCT04857489
- Effect of Variance on Error Correction During CouplingCompletedNCT04856384Not applicable
- Running Title: Walking to Music and in Silence on a TreadmillCompletedNCT04856345Not applicable
- Symptom Burden in Patients Treated With Ocrelizumab for Multiple SclerosisCompletedNCT04855617
- Investigation of the Effects of Selective Exercise Training in Multiple SclerosisCompletedNCT04853654Not applicable
- GentleCath Air (Urinary Self-catheterization) - Pain in Female Patients With Neurological Vesico-sphincter DisordersWithdrawnNCT04847609
- A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With OfatumumabCompletedNCT04847596
- Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised PeopleCompletedNCT04844489Not applicable
- Effects of Lutein Supplementation on Cognition and MPOD in Multiple Sclerosis Patients-Status unknownNCT04843813Not applicable
- Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA)CompletedNCT04843774
- TELEMS: Feasibility of Remote Patient Visits in MSCompletedNCT04838990Not applicable
- The Effect of Telerehabilitation Based Pilates Training in Multiple Sclerosis PatientsCompletedNCT04838886Not applicable
- Retrospective Study on Registry Data to Evaluate the Impact of Ocrelizumab Used in Routine Care in Patients With RRMSStatus unknownNCT04838015
- Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or NatalizumabCompletedNCT04837651
- Impact of Neuropsychological Disorders in Multiple SclerosisCompletedNCT04837365Not applicable
- Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple SclerosisCompletedNCT04834401
- The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized TrialCompletedNCT04833673Not applicable
- Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis ParticipantsCompletedNCT04832399
- Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple SclerosisCompletedNCT04823000Phase 1/2
- Imaging Evaluation of Central Nervous Autoimmune DiseasesStatus unknownNCT04822623
- Study of the Mechanisms of Action of Cladribine in Multiple SclerosisCompletedNCT04821596Not applicable
- Botulinum Toxin a Vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients with Multiple SclerosisTerminatedNCT04819360Phase 4
- The Use of Arabic Otago Exercise Program in People With Multiple SclerosisCompletedNCT04818008Not applicable
- Virtual Reality in Physical Therapy in Multiple SclerosisCompletedNCT04807738Not applicable
- MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients With Multiple SclerosisActive, not recruitingNCT04806568Not applicable
- Nature of the Link Between Executive Functions and Theory of Mind in Multiple SclerosisStatus unknownNCT04806217Not applicable
- Emotions in Multiple SclerosisCompletedNCT04804787Not applicable
- Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating MedicationTerminatedNCT04796584
- Role of Individualized Versus Traditional Exercise in Combating FatigueTerminatedNCT04796272Not applicable
- Post-COntrast 3D SE T1 Versus Coronal SE T1-WI MRI in Detecting Optic Neuritis (COCON)CompletedNCT04793087
- 3D FLAIR Versus Coronal T2-WI MRI in Detecting Optic Neuritis (FLACON)CompletedNCT04792866
- T Cell Profiling in Patients With Multiple SclerosisWithdrawnNCT04789551
- Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMSCompletedNCT04788615Phase 3
- The Effect of Extra Virgin Olive Oil in People With Multiple SclerosisActive, not recruitingNCT04787497Not applicable
- Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple SclerosisCompletedNCT04786821Not applicable
- ATOMIC (Active Teens Multiple Sclerosis) Physical Activity Research ProgramActive, not recruitingNCT04782466Not applicable
- Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple SclerosisCompletedNCT04777539
- miRNA Biomarkers in Multiple SclerosisCompletedNCT04772495
- Digital Gait Analysis in the Home Environment of Patients With Multiple SclerosisCompletedNCT04771858
- Histaminergic Basis of Fatigue in Multiple SclerosisWithdrawnNCT04764383Phase 2
- Power Training in Older Multiple Sclerosis PatientsStatus unknownNCT04762342Not applicable
- A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.CompletedNCT04760990
- Effects of Digital Pelvic Floor Muscle Training in Patients With Multiple Sclerosis Having Lower Urinary Tract SymptomsStatus unknownNCT04759391Not applicable
- Quality of Life Assessment Between Stroke and Multiple Sclerosis Patients of the Same Age RangeCompletedNCT04758494
- Effects of Telerehabilitation-Based Pelvic Floor Muscle Training in People With Multiple SclerosisCompletedNCT04758468Not applicable
- Validation of DigiCog and Konectom Tools to Support Digitalized Clinical Assessment in Multiple SclerosisCompletedNCT04756700Not applicable
- Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by TecfideraCompletedNCT04756687
- The 3-Meter Backward Walk Test in Individuals With Multiple SclerosisStatus unknownNCT04753411
- Impact of Core Performance on Functional Parameters in Multiple SclerosisCompletedNCT04750733
- Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple SclerosisActive, not recruitingNCT04749667Phase 1/2
- Impaired Glucose Tolerance and Cognition in MSTerminatedNCT04748302
- Barriers to Physical Activity in People With MSCompletedNCT04746807
- Tele-Assessment and Face-to-Face Evaluation of Balance in MSCompletedNCT04743284
- The MS-LINK™ Outcomes StudyCompletedNCT04735406
- Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy VolunteersCompletedNCT04725175Phase 1
- AIM's Writing for Healing: A Workshop for Individuals Living With ParalysisCompletedNCT04721717
- The Minnesota Manual Dexterity Test As A Measure Of Hand Function in Multiple SclerosisCompletedNCT04721340
- LUNA-EMG to Enhance Motor Functions in Multiple SclerosisCompletedNCT04720898Not applicable
- Dynamic Balance Training in Multiple SclerosisCompletedNCT04719494Not applicable
- A ToM Training for People With Multiple Sclerosis: an Efficacy Study.Status unknownNCT04711941Not applicable
- A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple SclerosisActive, not recruitingNCT04711148Phase 2
- Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5TCompletedNCT04707144
- Comparison of the Performance of an Optimized 3D EPI SWI Sequence and a Non-EPI QSM SWI Sequence in Detecting the Central Vein Sign in Patients With Multiple SclerosisCompletedNCT04705870
- Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculographyCompletedNCT04705610Not applicable
- Eye Movements Recording Using a Smartphone: Comparison to Standard Video-oculography in Patients With Multiple SclerosisCompletedNCT04702763
- The Added Value of Cognition-targeted Exercise Versus Symptom-targeted Exercise for Multiple Sclerosis FatigueCompletedNCT04699370Not applicable
- IL-2 Signaling and Polarization of Regulatory LBs: Involvement in Multiple SclerosisCompletedNCT04697407Not applicable